Cargando…

The HIV-1 transmission bottleneck

It is well established that most new systemic infections of HIV-1 can be traced back to one or a limited number of founder viruses. Usually, these founders are more closely related to minor HIV-1 populations in the blood of the presumed donor than to more abundant lineages. This has led to the widel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kariuki, Samuel Mundia, Selhorst, Philippe, Ariën, Kevin K., Dorfman, Jeffrey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364581/
https://www.ncbi.nlm.nih.gov/pubmed/28335782
http://dx.doi.org/10.1186/s12977-017-0343-8
_version_ 1782517350000492544
author Kariuki, Samuel Mundia
Selhorst, Philippe
Ariën, Kevin K.
Dorfman, Jeffrey R.
author_facet Kariuki, Samuel Mundia
Selhorst, Philippe
Ariën, Kevin K.
Dorfman, Jeffrey R.
author_sort Kariuki, Samuel Mundia
collection PubMed
description It is well established that most new systemic infections of HIV-1 can be traced back to one or a limited number of founder viruses. Usually, these founders are more closely related to minor HIV-1 populations in the blood of the presumed donor than to more abundant lineages. This has led to the widely accepted idea that transmission selects for viral characteristics that facilitate crossing the mucosal barrier of the recipient’s genital tract, although the specific selective forces or advantages are not completely defined. However, there are other steps along the way to becoming a founder virus at which selection may occur. These steps include the transition from the donor’s general circulation to the genital tract compartment, survival within the transmission fluid, and establishment of a nascent stable local infection in the recipient’s genital tract. Finally, there is the possibility that important narrowing events may also occur during establishment of systemic infection. This is suggested by the surprising observation that the number of founder viruses detected after transmission in intravenous drug users is also limited. Although some of these steps may be heavily selective, others may result mostly in a stochastic narrowing of the available founder pool. Collectively, they shape the initial infection in each recipient.
format Online
Article
Text
id pubmed-5364581
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53645812017-03-24 The HIV-1 transmission bottleneck Kariuki, Samuel Mundia Selhorst, Philippe Ariën, Kevin K. Dorfman, Jeffrey R. Retrovirology Commentary It is well established that most new systemic infections of HIV-1 can be traced back to one or a limited number of founder viruses. Usually, these founders are more closely related to minor HIV-1 populations in the blood of the presumed donor than to more abundant lineages. This has led to the widely accepted idea that transmission selects for viral characteristics that facilitate crossing the mucosal barrier of the recipient’s genital tract, although the specific selective forces or advantages are not completely defined. However, there are other steps along the way to becoming a founder virus at which selection may occur. These steps include the transition from the donor’s general circulation to the genital tract compartment, survival within the transmission fluid, and establishment of a nascent stable local infection in the recipient’s genital tract. Finally, there is the possibility that important narrowing events may also occur during establishment of systemic infection. This is suggested by the surprising observation that the number of founder viruses detected after transmission in intravenous drug users is also limited. Although some of these steps may be heavily selective, others may result mostly in a stochastic narrowing of the available founder pool. Collectively, they shape the initial infection in each recipient. BioMed Central 2017-03-23 /pmc/articles/PMC5364581/ /pubmed/28335782 http://dx.doi.org/10.1186/s12977-017-0343-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Kariuki, Samuel Mundia
Selhorst, Philippe
Ariën, Kevin K.
Dorfman, Jeffrey R.
The HIV-1 transmission bottleneck
title The HIV-1 transmission bottleneck
title_full The HIV-1 transmission bottleneck
title_fullStr The HIV-1 transmission bottleneck
title_full_unstemmed The HIV-1 transmission bottleneck
title_short The HIV-1 transmission bottleneck
title_sort hiv-1 transmission bottleneck
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364581/
https://www.ncbi.nlm.nih.gov/pubmed/28335782
http://dx.doi.org/10.1186/s12977-017-0343-8
work_keys_str_mv AT kariukisamuelmundia thehiv1transmissionbottleneck
AT selhorstphilippe thehiv1transmissionbottleneck
AT arienkevink thehiv1transmissionbottleneck
AT dorfmanjeffreyr thehiv1transmissionbottleneck
AT kariukisamuelmundia hiv1transmissionbottleneck
AT selhorstphilippe hiv1transmissionbottleneck
AT arienkevink hiv1transmissionbottleneck
AT dorfmanjeffreyr hiv1transmissionbottleneck